SEC Form 4 · accession 0001209191-15-052073
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Craig Thompson
Officer — Chief Operating Officer
Period of report
Jun 8, 2015
Accepted (ET)
Jun 10, 2015 · 8:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2015 | M | 22,499 | $14.45 | A | 22,842 | D | |
| Common Stock | Jun 8, 2015 | S | 11,862 | $43.50 | D | 10,980 | D | |
| Common Stock | Jun 8, 2015 | S | 10,637 | $43.00 | D | 343 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $14.45 | Jun 8, 2015 | M | 22,499 | D | — | Feb 2, 2024 | Common Stock | 22,499 | 197,501 | D |
Explanation of responses
- F1This option vested as to 20% of the shares on February 3, 2014 and another 20% on February 3, 2015 and further vests as to 5% of the shares at the end of each successive three-month period thereafter until February 3, 2018.